Financed by EU fonds

Projects

The project is led by Sartorius Croatia - Libra Elektronik d.o.o., in collaboration with Genera Research d.o.o., Dario Bekavac Dental Clinic, and the Laboratory for Mineralized Tissues at the University of Zagreb School of Medicine. The managing authority is the Ministry of Regional Development and EU Funds, and the intermediary body for operations is the Croatian Agency for SMEs, Innovation, and Investments. The project will be implemented within the SPIN consortium and will contribute to the industrial transition of the region towards an advanced healthcare industry, fostering innovation and competitiveness in Northern Croatia. Project manager and contact person: Josipa Smoljo Marušić e-mail: Josipa.Marusic@sartorius.hr tel.: +385 1 3340 290

Cerm

Program

Strengthening Strategic Partnerships for Innovation in the Process of Industrial Transition (within the Integrated Territorial Program)

Duration

January 13, 2025 – January 12, 2028

Location

Zagreb, Croatia

Project funding

Total Project Value: €4,674,018.25 EU Contribution: €2,703,830.46

Project goals

The project addresses the challenge of insufficient bone tissue regeneration in dental medicine, which is a significant obstacle in dental implant placement. The goal is to develop an autologous substitute for dental bone grafts.


Project results

The project will significantly impact the research community, dental medicine, and industrial transition in Northern Croatia. The results will be presented in relevant scientific journals and at international conferences, increasing the visibility of Croatian research capacities in biomedicine and dental medicine. In the long term, the project will provide tangible benefits to dental professionals, patients, and scientists, reducing the need for invasive procedures and improving dental treatment outcomes.

Read more

The project aims to solve the problem of limited bone tissue regeneration in dental medicine, which complicates successful dental implant placement. The objective is to develop an innovative autologous bone tissue substitute. This approach will enable safer and more efficient alveolar ridge regeneration, reducing the need for complex surgical procedures. The project involves research and development of minimally invasive therapy for alveolar ridge augmentation using personalized formulations. The SPIN consortium, comprising experts from various fields, has been established to achieve the research goals. The research will last for a total of 36 months and is divided into two main phases: Industrial Research Phase (10 months) Experimental Development Phase (26 months)

Supported by

Eu commision logo
Eu elbem